Vimarsana
Biggest News Aggregation in the World

Page 2 - Repeatable Battery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repeatable Battery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repeatable Battery Today - Breaking & Trending Today

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023 - Vimarsana News

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 -- Axsome Therapeutics, Inc. , a... | June 1, 2023

Sex Differences in Cognitive Impairment Identified in Schizophrenia and Tardive Dyskinesia - Vimarsana News

Sex Differences in Cognitive Impairment Identified in Schizophrenia and Tardive Dyskinesia

There may be sex differences in cognitive impairment, with a protective effect suggested by female gender in patients with schizophrenia and tardive dyskinesia.

Sex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia - Vimarsana News

Sex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia

For patients with schizophrenia and tardive dyskinesia (TD), there may be sex differences in cognitive impairment.

Aerobic Exercise: Benefits Following Brain Injury - Vimarsana News

Aerobic Exercise: Benefits Following Brain Injury

After a traumatic brain injury, aerobic exercise promotes cardiovascular fitness, cognitive recovery, and reductions in mood disorders.

Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of Neurology (AAN) Annual Meeting - Vimarsana News

Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of Neurology (AAN) Annual Meeting

NEW YORK, April 21, 2023 -- Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today... | April 21, 2023